Splenic Atrophy in Experimental Stroke Is Accompanied by Increased Regulatory T Cells and Circulating Macrophages
Top Cited Papers
- 1 June 2006
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 176 (11) , 6523-6531
- https://doi.org/10.4049/jimmunol.176.11.6523
Abstract
Induction of stroke not only produces local ischemia and brain damage, but also has profound effects on peripheral immune responses. In the current study, we evaluated effects on spleen and blood cells 4 days after stroke induction. Surprisingly, there was a less inflammatory cytokine profile in the middle cerebral artery occlusion-affected right brain hemisphere at 96 h compared with earlier time points. Moreover, our results demonstrate that stroke leads to splenic atrophy characterized by a reduction in organ size, a drastic loss of splenocyte numbers, and induction of annexin V+ and TUNEL+ cells within the spleen that are in the late stages of apoptosis. The consequence of this process was to reduce T cell proliferation responses and secretion of inflammatory cytokines, resulting in a state of profound immunosuppression. These changes produced a drastic reduction in B cell numbers in spleen and blood, and a novel increase in CD4+FoxP3+ regulatory T cells. Moreover, we detected a striking increase in the percentage of nonapoptotic CD11b+ VLA-4-negative macrophages/monocytes in blood. Immunosuppression in response to brain injury may account for the reduction of inflammatory factors in the stroke-affected brain, but also potentially could curtail protective immune responses in the periphery. These findings provide new evidence to support the contention that damage to the brain caused by cerebral ischemia provides a powerful negative signal to the peripheral immune system that ultimately induces a drastic state of immunosuppression caused by cell death as well as an increased presence of CD4+FoxP3+ regulatory T cells.Keywords
This publication has 35 references indexed in Scilit:
- Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of treg cells, and enhanced expression of the PD-1 costimulatory pathwayJournal of Neuroscience Research, 2006
- Lateralization in autononic dysfunction in ischemic stroke involving the insular cortexNeuroReport, 2004
- Control of Regulatory T Cell Development by the Transcription Factor Foxp3Science, 2003
- Desferrioxamine Induces Delayed Tolerance against Cerebral Ischemia in Vivo and in VitroJournal of Cerebral Blood Flow & Metabolism, 2002
- Regulatory T Cells in AutoimmmunityAnnual Review of Immunology, 2000
- Interleukin-1 Receptor and Receptor Antagonist Gene Expression After Focal Stroke in RatsStroke, 1997
- Monocyte Chemoattractant Protein–1 Messenger RNA Expression in Rat Ischemic CortexStroke, 1995
- Expression of Interleukin-6, c-Fos, and zif268 mRNAs in Rat Ischemic CortexJournal of Cerebral Blood Flow & Metabolism, 1995
- Tumor necrosis factor-alpha expression in ischemic neurons.Stroke, 1994
- Interleukin-1 beta mRNA expression in ischemic rat cortex.Stroke, 1993